It is possible that the release of EGF and many other RTK ligands (e.g., VEGF, bFGF, HGF) is induced as a consequence of TNFα activation, leading to RTK activation and then to cooperation in the release of CXCL8 by the tumor cells. The gene discussed is FGF2; the disease is neoplasm.